MoonLake Immunotherapeutics (MLTX)
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
Anixa Biosciences Inc. (ANIX)
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Heart Test Laboratories Inc (HSCSW)
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
Westlake Chemical Corporation (WLK)
Westlake - Westlake to Rationalize Certain North American Chlorovinyl and Styrene Assets
Gilead Sciences Inc (GILD)
Gilead - Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial
Vicarious Surgical Inc (RBOT)
Vicarious Surgical Inc. - Vicarious Surgical Announces Full Year 2026 Cash Burn Guidance
Heart Test Laboratories Inc (HSCS)
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
GeneDx Holdings (WGS)
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
GeneDx Holdings (WGSWW)
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
Gilead Sciences Inc (GILD)
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial